In conclusion, integration of individualized genomic profiling and drug screening of patient-derived models of neuroblastoma showed that susceptibility to PI3K and cell cycle agents was significantly associated with copy number gains of PI3K and STAT family genes, particularly on 17q. The gene discussed is SOAT1; the disease is neuroblastoma.